Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4045-4052

  Chambers, Mark ^a,f   Dougan, Gordon ^a   Newman, John ^e   Brown, Fred ^d   Crowther, John ^b   Paul Mould, A ^c   Humphries, Martin J ^c   Francis, Michael J ^b,g   Clarke, Berwyn ^b   Brown, Alan L ^b   Rowlands, David ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^e AGRICULTURAL RESEARCH SERVICE   (United States)

^f ST MARY S HOSPITAL   (United Kingdom)

^g Mallinckrodt Veterinary Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; INTEGRIN; NEUTRALIZING ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FOOT AND MOUTH DISEASE VIRUS; GENE INSERTION; GUINEA PIG; HEPATITIS B; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS EXPRESSION;

ANIMALS; APHTHOVIRUS; CELL LINE; FEMALE; GUINEA PIGS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTEGRINS; OLIGOPEPTIDES; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; VIRAL CORE PROTEINS;

EID: 0029888094     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. Rowlands, and F. Brown. 1989. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature (London) 337:709-716.
2. Argos, P., and S. D. Fuller. 1988. A model for the hepatitis B virus core protein: prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J. 7:819-824.
3. Baxt, B., and Y. Becker. 1990. The effect of peptides containing the arginine-glvcine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4:73-83.
4. Berinstein, A., M. Roivainen, T. Hovi, P. W. Mason, and B. Baxt. 1995. Antibodies to the vitronectin receptor (integrin αV β3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666.
5. Bittle, J. L., R. A. Houghten, H. Alexander, T. M. Shinnick, J. G. Sutcliffe, R. A. Lerner, D. J. Rowlands, and F. Brown. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature (London) 298:30-33.
6. Brown, A. L., M. J. Francis, G. Z. Hastings, N. R. Parry, P. V. Barnetl, D. J. Rowlands, and B. E. Clarke. 1991. Foreign epitopes in immunodominant regions of hepatitis B core particles arc highly immunogenic and conformationally restricted. Vaccine 9:595-601.
7. Brown, F., and B. Cartwright. 1963. Purification of radioactive foot-andmouth disease virus. Nature (London) 199:1168-1170.
8. Charo, I. F., L. Nannizzi, J. W. Smith, and D. A. Cheresh. 1990. The vilronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111:2795-2800.
9. Cherny, R. C., M. A. Honan, and P. Thiagarajan. 1993. Site-directed mutagcnesis of the arginine-glvcine-aspartic acid in vitronectin abolishes cell adhesion. J. Biol. Chern. 268:9725-9729.
10. Clarke, B. E., A. L. Brown, K. G. Grace, G. Z. Hastings, F. Brown, D. J. Rowlands, and M. J. Francis. 1990. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria. J. Gen. Virol. 71:1109-1117.
11. Clarke, B. E., S. E. Newton, A. R. Carroll, M. J. Francis, G. Appleyard, A. D. Syred, P. E. Highfleld, D. J. Rowlands, and F. Brown. 1987. Improved immunogenicity of a peptide epitopc after fusion to hepatitis B core protein. Nature (London) 330:381-384.
12. Crowther, R. A., N. A. Kiselev, B. Bottcher, J. A. Berriman, G. P. Borisova, V. Ose, and P. Pumpens. 1994. Three-dimensional structure of hepatitis B virus core particles determined by electron crynmicroscopy. Cell 77:943-950.
13. DiMarchi, R., G. Brooke, C. Gale, V. Cracknell, T. Doel, and N. Mowat. 1986. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639-641.
14. Fox, G., N. R. Parry, P. V. Barnett, B. McGinn, D. J. Rowlands, and F. Brown. 1989. The cell attachment site on foot-and-mouth disease virus includes the arnino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:625-637.
15. Logan, D., R. Abu Ghazaleh, W. Blakemore, S. Curry, T. Jackson, A. King, S. Lea, R. Lewis, J. Newman, N. Parry, et al. 1993. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (London) 362:566-568.
16. MacKay, P., J. Lees, and K. Murray. 1981. The conversion of hepatitis B core antigen synthesized in E. coli into e antigen. J. Med. Virol. 8:237-243.
17. Makarem, R., P. Newham, J. A. Askari, L. J. Green, J. Clements, M. Edwards, M. J. Humphries, and A. P. Mould. 1994. Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1. J. Biol. Chem. 269:4005-4011.
18. Mason, P. W., B. Baxt, F. Brown, J. Harber, A. Murdin, and E. Wimmer. 1993. Antibody-complcxed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568-577.
19. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-andmouse disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
20. Morgan, D. O., and D. M. Moore. 1990. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am. J. Vet. Res. 51:40-45.
21. Mulcahy, G., C. Gale, P. Robertson, S. Iyisan, R. D. DiMarchi, and T. R. Doel. 1990. fsotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8:249-256.
22. Obara, M., and K. Voshizato. 1995. Possible involvement of the interaction of the alpha 5 subunit of alpha 5 beta 1 integrin with the synergistic region of the central cell-binding domain of fibronectin in cells to fibronectin binding. Exp. Cell Res. 216:273-276.
23. Rieder, E., B. Baxt, and P. W. Mason. 1994. Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J. Virol. 68:5296-5299.
24. Ruoslahti, E., and M. D. Pierschbacher. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
25. Rweyemamu, M. M., J. C. Booth, M. Head, and T. W. Pay. 1978. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J. Hyg. 81:107-123.
26. Sekiguchi, K., A. J. Franke, and B. Baxt. 1982. Competition for cellular receptor sites among selected aphthoviruses. Arch. Virol. 74:53-64.
27. Strohraaier, K., R. Franze, and K. H. Adam. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59:295-306.
28. Surovoi, A., V. T. Ivanov, A. V. Chepurkin, V. N. Ivaniushchenkov, and N. N. Driagalin. 1988. Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor? Bioorg. Khim. 14:965-968.
29. Voller, A., A. Bartlett, D. E. Bidwell, M. F. Clark, and A. N. Adams. 1976. The detection of viruses by enzyme-linked immunosorbent assay (ELISA). J. Gen. Virol. 33:165-167.